ASWP Admin

AI Drug Discovery

Alnylam Forges $2 Billion AI Alliance with Inceptive to Revolutionize RNA Drug Discovery

Alnylam Pharmaceuticals, a leader in RNA interference (RNAi) therapeutics, has announced a significant strategic collaboration with Inceptive, an emerging force in artificial intelligence-driven drug discovery. This ambitious partnership, potentially valued at up to $2 billion, aims to revolutionize the identification and development of novel RNA-based medicines. The alliance underscores a

By ASWP Admin

AI Medical Devices

Navigating the Future: FDA's Evolving Oversight of AI in Medical Devices

The integration of Artificial Intelligence (AI) and Machine Learning (ML) into medical devices marks a transformative era in healthcare, promising unprecedented advancements in diagnosis, treatment, and patient care. From sophisticated diagnostic imaging tools that can detect subtle anomalies to predictive analytics for disease progression, AI-powered devices are rapidly moving from

By ASWP Admin

AI Regulation

Trump's Landmark Executive Order Demands Government Oversight of Frontier AI Models

In a significant move poised to reshape the landscape of artificial intelligence development, former President Donald Trump signed an executive order mandating government access to advanced, or “frontier,” AI models. The order, issued during his administration, aimed to establish a framework for federal oversight, citing national security concerns, economic competitiveness,

By ASWP Admin
Follow our other news and article networks here:
The Daily Watch Feeds
The Daily Watch News
The Daily Something Articles
The Daily Watch Articles
The Daily Somehting Feeds
The Daily Somehting News